Development, Characterization & Statistical Optimization of Matrix Type Transdermal Patches of Almotriptan Malate for The Treatment of Migraine
Akila RM1*, Naseem AK1
College of Pharmacy, Department of
Pharmaceutics, Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore
ABSTRACT
The
present work is focused on the development, evaluation and statistical
optimization of almotriptan malate transdermal patches. Almotriptan malate is
used as anti-migraine drug and reported to have the best-sustained pain free
rate and the lowest adverse events rate of all the triptans and thus making
interest in the development of new route for the therapeutic administration of
the drug, So, the present research work was aimed to develop matrix type transdermal patches using polymers HPMC K15M, ERS100 and EC and
plasticizers DBP and PEG400 by solvent casting method. This formulation would
help to avoid non-compliance of the tablet dosage form The IR spectra of the
drug and physical mixtures of drug-polymer confirmed the absence of
incompatibility between drug and polymers. The in-vitro drug release studies revealed
that patches made of HPMC K15M-ERS 100 with DBP as plasticizer was considered
as the best formulation and incorporated in 22 factorial design and
evaluated for further studies. The
concentration of HPMC K 15M and ERS 100 are chosen as the independent
variables. Drug content, %moisture
absorption %, moisture loss, and
cumulative % drug released at 12h are chosen as dependent variables. The drug
release from transdermal patches followed zero order kinetics. Various
physicochemical parameters of the patches were investigated. The current
research work of transdermal patches of almotriptan malate may provide
sustained delivery for prolonged periods in the management of migraine, which
can be a good way to bypass the extensive hepatic first-pass metabolism.
Keywords: migraine, almotriptan
malate, transdermal patches, solvent casting, 22 factorial design